Are There Any Clinical Trials Focusing on Cholesterol Biosynthesis Inhibitors in Cancer?
Several clinical trials are investigating the use of cholesterol biosynthesis inhibitors in cancer treatment. Statins have been evaluated in combination with traditional chemotherapy and other targeted therapies. Early results from these trials suggest that statins may enhance the efficacy of existing cancer treatments. However, more research is needed to fully understand the therapeutic potential and safety of targeting cholesterol biosynthesis in cancer patients.
